Last updated: January 13, 2026
Sponsor: Institut Bergonié
Overall Status: Active - Recruiting
Phase
N/A
Condition
Uterina Myoma
Treatment
No intervention
Clinical Study ID
NCT06540846
IB2023-STUMP
Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with a diagnosis of uterine smooth muscle tumors (leiomyomas, smooth muscletumors of uncertain malignancy and leiomyosarcomas), registered in the RRePSdatabase and/or treated at Institut Bergonié or one of the participating centers.
Histopathological material available (kerosene blocks and/or slides).
The follow-up (outcome) is required for each LMS/ STUMP.
Exclusion
Exclusion Criteria:
- na
Study Design
Total Participants: 392
Treatment Group(s): 1
Primary Treatment: No intervention
Phase:
Study Start date:
December 01, 2023
Estimated Completion Date:
December 31, 2026
Connect with a study center
Institut Bergonie
Bordeaux,
FranceSite Not Available
Institut Bergonie
Bordeaux 3031582,
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.